This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (1729)
Death (95)
Life Threatening Events (62)
Disability (63)
Reports by Reaction Type
Anaemia (322),
Nausea (195),
Fatigue (185),
Rash (166),
Decreased Appetite (127),
Vomiting (124),
Weight Decreased (121),
Asthenia (117),
Haemoglobin Decreased (112),
Malaise (104),
Dyspnoea (99),
White Blood Cell Count Decreased (93)
Below are a few examples of reports where side effects / adverse reactions may be related to PEG-Intron (Peginterferon Alfa-2B). For a complete list or a specific selection of reports, please use the links above.
Possible PEG-Intron side effects in
Reported by a individual with unspecified qualification from Germany on 2012-08-27
Patient:
Reactions: Maternal Exposure Before Pregnancy, Abortion Induced
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis
End date: 2012-01-01
Rebetol
Dosage: unk
End date: 2012-01-01
Victrelis
Dosage: 200 mg, qd
Indication: Hepatitis
Start date: 2012-01-09
End date: 2012-05-01
Other drugs received by patient: Lexotanil
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient:
Reactions: White Blood Cell Count Decreased, Contusion, Anaemia, Fall, Loss of Consciousness, Haemoglobin Decreased, Anxiety, Dysgeusia, Urine Uric Acid Increased, Disturbance in Attention, Injury, Feeling Abnormal, Asthenia
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-03-03
Rebetol
Dosage: unk unk, qam
Indication: Hepatitis C
Start date: 2012-03-03
Rebetol
Dosage: unk unk, qpm
Rebetol
Dosage: unk unk, qam
Rebetol
Dosage: unk unk, qpm
Start date: 2012-03-03
Rebetol
Dosage: unk unk, qpm
Rebetol
Dosage: unk unk, qam
Victrelis
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-03-31
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient:
Reactions: Injection Site Erythema, Nasal Dryness, Epistaxis
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-07-16
Rebetol
Dosage: unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-07-16
Victrelis
Dosage: unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-08-20
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-27
Patient:
Reactions: Fatigue, Nausea, Headache
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 microgram, qw
Rebetol
Administration route: Oral
Other drugs received by patient: Zyrtec; Lisinopril; Nortriptyline HCL; Atenolol; Prilosec; Estradiol
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Psychiatric Symptom
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-02-21
End date: 2012-03-16
Rebetol
Dosage: cumulative dose: 20000 mg
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-21
End date: 2012-03-13
Rebetol
Dosage: cumulative dose: 20000 mg
Administration route: Oral
Start date: 2012-03-13
End date: 2012-03-16
Telavic
Dosage: cumulative dose: 56250 mg
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-21
End date: 2012-03-16
Other drugs received by patient: Loxoprofen; Allopurinol
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient:
Reactions: Back Pain, Drug Ineffective, Swelling
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-07-24
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-07-24
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-08-21
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient:
Reactions: Back Pain
Drug(s) suspected as cause:
PEG-Intron
Indication: Hepatitis C
Rebetol
Administration route: Oral
Indication: Hepatitis C
Victrelis
Administration route: Oral
Indication: Hepatitis C
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Anaemia, Rash, Haemolytic Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Antiviral (Unspecified)
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-31
End date: 2012-03-16
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-01-31
End date: 2012-03-15
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-04-24
End date: 2012-05-21
Ribavirin
Dosage: 500 mg, qd
Administration route: Oral
Start date: 2012-05-22
Ribavirin
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-03-21
End date: 2012-04-03
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-31
End date: 2012-02-27
Ribavirin
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-02-28
End date: 2012-03-17
Ribavirin
Dosage: 300 mg, qd
Administration route: Oral
Start date: 2012-04-04
End date: 2012-04-23
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-31
End date: 2012-03-16
Other drugs received by patient: Coniel; Famotidine; Allopurinol; Celestamine (Betamethasone (+) Dexchlorpheniramine Maleate (+) Fluphen; Isosorbide Dinitrate
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Pancreatitis Acute, Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-05-11
End date: 2012-06-15
Rebetol
Dosage: 800 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-11
End date: 2012-06-20
Telaprevir
Dosage: 2250 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-11
End date: 2012-06-20
Other drugs received by patient: Talion (Bepotastine Besylate); Feburic; Famostagine D; NEO-Minophagen C; Urdeston; Trebianom; Sitagliptin Phosphate
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Rash
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, unk
Start date: 2012-06-19
Rebetol
Dosage: 600 mg, unk
Administration route: Oral
Start date: 2012-06-19
Rebetol
Dosage: 400 mg, unk
Administration route: Oral
Start date: 2012-07-03
Telavic
Dosage: 2250 mg, unk
Administration route: Oral
Start date: 2012-06-19
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Anaemia, Blood Uric Acid Increased, Decreased Appetite
Drug(s) suspected as cause:
PEG-Intron
Dosage: 30 microgram per kilogram, qw
Start date: 2012-07-05
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-06-14
End date: 2012-06-21
PEG-Intron
Dosage: 50 microgram per kilogram, qw
Start date: 2012-07-12
PEG-Intron
Dosage: 70 microgram per kilogram, qw
Start date: 2012-07-19
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-14
End date: 2012-06-27
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-07-05
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-14
End date: 2012-06-27
Other drugs received by patient: Theo-DUR; Lendormin; Mucodyne
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-27
Patient:
Reactions: Exposure VIA Father
Drug(s) suspected as cause:
PEG-Intron
Possible PEG-Intron side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: female
Reactions: Dehydration, Anaemia, Lower Respiratory Tract Inflammation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-02-15
Ribavirin
Dosage: unk
Indication: Hepatitis C
Start date: 2012-02-15
VX-950
Dosage: 750 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-15
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient:
Reactions: Myalgia, Injection Site Haemorrhage, Nausea, Chills, Sinus Headache, Hyperhidrosis, Muscle Spasms
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-07-22
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-07-22
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Malaise, Renal Impairment, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, unk
Indication: Hepatitis C
Start date: 2012-06-06
Rebetol
Dosage: 600 mg, unk
Administration route: Oral
Start date: 2012-06-15
End date: 2012-06-20
Rebetol
Dosage: 200 mg, unk
Administration route: Oral
Start date: 2012-06-21
End date: 2012-07-12
Rebetol
Dosage: 800 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-06
End date: 2012-06-14
Rebetol
Dosage: 200 mg, qod
Administration route: Oral
Start date: 2012-07-13
Telavic
Dosage: 1500 mg, unk
Administration route: Oral
Start date: 2012-06-08
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-06
End date: 2012-06-07
Other drugs received by patient: Lendormin; Lansoprazole; Amoban
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-27
Patient:
Reactions: Gingival Pain, Glossodynia, Stomatitis, LIP Pain
Drug(s) suspected as cause:
PEG-Intron
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Interstitial Lung Disease, Oedema, Hepatic Failure
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bactrim
Dosage: 1 df, once
Administration route: Oral
Indication: Adverse Event
End date: 2012-06-09
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-03-13
End date: 2012-04-04
Rebetol
Dosage: 800 mg, once
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-13
End date: 2012-04-04
Telavic
Dosage: 2250 mg, once
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-13
End date: 2012-04-04
Other drugs received by patient: Urso 250; Lasix; Celestamine TAB; NEO-Minophagen C; Aldactone
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Drug Eruption, Haemoglobin Decreased, Malaise, Hyperglycaemia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-05-17
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-17
End date: 2012-06-13
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-06-14
End date: 2012-06-28
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-07-18
End date: 2012-07-26
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-17
End date: 2012-05-25
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Other drugs received by patient: Motilium; Gasmotin; Diflorasone Diacetate; Nizatidine
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient:
Reactions: Headache
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-07-16
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-07-17
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-08-12
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Rash
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-05-07
Rebetol
Dosage: 200 mg, unk
Administration route: Oral
Start date: 2012-06-25
End date: 2012-07-30
Rebetol
Dosage: 400 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-07
End date: 2012-06-24
Telavic
Dosage: 1500 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-07
End date: 2012-07-08
Other drugs received by patient: Loxonin; Olopatadine HCL; Allopurinol; Betamethasone Sodium Phosphate
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Anaemia
Drug(s) suspected as cause:
Antiviral (Unspecified)
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-04
PEG-Intron
Dosage: 1.5 ?g/kg, qw
Indication: Hepatitis C
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-02-08
Ribavirin
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
End date: 2012-02-07
Other drugs received by patient: Lorfenamin; Livalo; Epadel S; Claritin Reditabs; Sodium Ferrous Citrate
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Platelet Count Decreased
Drug(s) suspected as cause:
PEG-Intron
Dosage: 100 microgram, qw
Start date: 2012-05-02
End date: 2012-05-02
PEG-Intron
Dosage: 40 microgram, qw
Start date: 2012-06-06
End date: 2012-06-20
PEG-Intron
Dosage: 50 microgram, qw
Start date: 2012-04-18
End date: 2012-04-18
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-04-11
End date: 2012-04-11
PEG-Intron
Dosage: 30 microgram,
Start date: 2012-06-27
End date: 2012-06-27
PEG-Intron
Dosage: 75 microgram, qw
Start date: 2012-04-25
End date: 2012-04-25
PEG-Intron
Dosage: 50 microgram, qw
Start date: 2012-05-09
End date: 2012-05-30
PEG-Intron
Dosage: 40 microgram, unk
Start date: 2012-07-04
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-11
Telavic
Dosage: 1.5 g, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-11
End date: 2012-04-14
Telavic
Dosage: 1.5 g, qd
Administration route: Oral
End date: 2012-06-27
Telavic
Dosage: unk
Administration route: Oral
Start date: 2012-04-17
Other drugs received by patient: Glycyron; Talion (Bepotastine Besylate); Loxonin; Loxonin; Urso 250; NEO-Minophagen C; Motilium
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient:
Reactions: Liver Injury, Viral Load Increased, Drug Ineffective
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2009-01-01
End date: 2010-01-01
Pegasys
Dosage: unk
Start date: 2012-06-28
End date: 2012-08-02
Pegasys
Dosage: unk
Indication: Hepatitis C
Start date: 2010-01-01
End date: 2011-01-01
Rebetol
Dosage: unk
Start date: 2012-06-28
End date: 2012-08-02
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2010-01-01
End date: 2011-01-01
Telaprevir
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-28
End date: 2012-08-02
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Malaise
Drug(s) suspected as cause:
PEG-Intron
Dosage: 100 microgram per kilogram, unk
Indication: Hepatitis C
Start date: 2012-06-15
End date: 2012-07-13
Rebetol
Dosage: 800 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-15
Rebetol
Dosage: 400 mg, unk
Administration route: Oral
Start date: 2012-07-06
End date: 2012-07-13
Telavic
Dosage: 2250 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-15
Telavic
Dosage: 1500 mg, unk
Administration route: Oral
Start date: 2012-07-06
End date: 2012-07-13
Other drugs received by patient: Diflunisal; Januvia; Basen
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Renal Impairment, Anaemia, Pancreatitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-04-27
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-27
End date: 2012-05-24
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-05-25
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-27
End date: 2012-05-17
Other drugs received by patient: Antebate; Prednisolone; Dexaltin; Ubiron; Aspara CA; Loxonin; Onealfa; Diovan; Berizym (Lysozyme Chloride); Mirobect; Amlodipine; Isoleucine (+) Leucine (+) Valine; Lansoprazole; Mucosta
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: White Blood Cell Count Decreased, Renal Impairment, Anaemia, Platelet Count Decreased, Decreased Appetite
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 mcg /kg/week
Indication: Hepatitis C
Start date: 2012-04-13
End date: 2012-04-25
PEG-Intron
Dosage: 1.0 mcg /kg/week
Start date: 2012-06-26
PEG-Intron
Dosage: 1.0 mcg /kg/week
Start date: 2012-04-26
End date: 2012-06-06
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-13
End date: 2012-06-06
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-06-26
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-13
End date: 2012-06-07
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-06-26
End date: 2012-07-24
Other drugs received by patient: Motilium; Lorfenamin; Motilium; L Cartin; Rikkunshi-TO; Epadel
Possible PEG-Intron side effects in 59 year old female
Reported by a physician from Canada on 2012-08-27
Patient: 59 year old female, weighing 44.0 kg (96.8 pounds)
Reactions: Oesophageal Varices Haemorrhage, Ascites
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Incivek
Dosage: 750 mg, tid
Administration route: Oral
Indication: Hepatitis C
PEG-Intron
Dosage: 120 unk, unk
Indication: Hepatitis C
Other drugs received by patient: Nadolol; Lasix; Atenolol; Spironolactone; Eprex
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient:
Reactions: Irritability, Fatigue
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 ?g, qw
Indication: Hepatitis C
Start date: 2012-05-16
Ribavirin
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Orgasuline Rapide; Antiviral (Unspecified)
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Nausea
Drug(s) suspected as cause:
PEG-Intron
Dosage: 80 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-06-12
End date: 2012-06-17
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-12
End date: 2012-06-17
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-12
End date: 2012-06-17
Other drugs received by patient: Talion (Bepotastine Besylate); Mucosta; Loxonin
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-27
Patient:
Reactions: Product Quality Issue, NO Adverse Event, Underdose
Drug(s) suspected as cause:
PEG-Intron
|